← All organizations

Apricus Biosciences

For profitWebsite ↗

Also known as: NexMed, Inc. | NexMed (U.S.A.), Inc. | NEXMED (U.S.A.), Inc. | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 1, 2015

Acquired by Seelos Therapeutics on Jan 1, 2019

Timeline

1980s

Jun 1, 1987
Apricus Biosciences— Founded

2000s

Dec 14, 2009
Bio-Quant— Acquired

2010s

Dec 16, 2011
TopoTarget— Acquired
Jan 1, 2019
Seelos Therapeutics— Acquired By

Drugs by trial phase (3 distinct, 3 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

terbinafine

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (6)

NCT02443090Study directorPhase 2May 1, 2015
NCT02443090Lead sponsorPhase 2May 1, 2015
NCT02228850Study directorPhase 2Nov 1, 2014
NCT02228850Lead sponsorPhase 2Nov 1, 2014
NCT00691184Study directorPhase 1Feb 1, 2005
NCT00691184Lead sponsorPhase 1Feb 1, 2005

Details

Founded: San Diego, CA, US Jun 1, 1987
Last known activity: May 1, 2015